New Whitepaper Discusses How Best to Utilize Next Generation Techniques for Genomic Research
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has released a new white paper discussing the relative merits of DNA microarrays and next generation sequencing (NGS) for human genome analysis.
Although the development of genome analysis technologies such as DNA microarrays and NGS has provided the researcher with the unique ability to screen for sequence variants of clinical relevance, each technology has its own unique advantages, meaning that choosing the most appropriate technology for any given study can be challenging.
Therefore, the resulting whitepaper, which can be downloaded here, discusses the essential factors to consider when selecting the optimal platform for a specific study.
The white paper discusses issues such as the suitability of microarrays and sequencing for various applications, the relative costs associated with each technology and how to overcome the challenges posed by the analysis of large and complex datasets.
Although the development of genome analysis technologies such as DNA microarrays and NGS has provided the researcher with the unique ability to screen for sequence variants of clinical relevance, each technology has its own unique advantages, meaning that choosing the most appropriate technology for any given study can be challenging.
Therefore, the resulting whitepaper, which can be downloaded here, discusses the essential factors to consider when selecting the optimal platform for a specific study.
The white paper discusses issues such as the suitability of microarrays and sequencing for various applications, the relative costs associated with each technology and how to overcome the challenges posed by the analysis of large and complex datasets.
